Digital Health Tools for Addiction Treatment: Apps, Telehealth, and Technology

Introduction

Digital health technology is transforming addiction treatment, expanding access to evidence-based interventions for people who cannot access traditional treatment due to geographic, financial, or stigma-related barriers. From FDA-cleared smartphone apps to telehealth platforms to wearable biosensors, digital health tools are creating new possibilities for addiction prevention, treatment, and recovery support. Understanding the evidence base for these tools — and their limitations — is essential for making informed decisions about their use.

Key Definitions

Digital therapeutics (DTx): Software-based interventions that deliver evidence-based therapeutic interventions to prevent, manage, or treat medical conditions. Some DTx are FDA-cleared as medical devices.

Telehealth: The delivery of healthcare services using telecommunications technology, including video visits, phone consultations, and remote monitoring.

Ecological momentary assessment (EMA): The use of smartphones to collect real-time data on mood, craving, and behavior in daily life. Used in research and clinical monitoring.

Wearable biosensors: Devices worn on the body that continuously monitor physiological signals — heart rate, skin conductance, movement — that may indicate stress or craving.

FDA-cleared: A regulatory designation indicating that a medical device has been reviewed by the FDA and found to be substantially equivalent to a legally marketed device.

FDA-Cleared Digital Therapeutics for Addiction

reSET and reSET-O (Pear Therapeutics): The first FDA-cleared prescription digital therapeutics for substance use disorders. reSET is cleared for alcohol, cocaine, marijuana, and stimulant use disorders; reSET-O is cleared for opioid use disorder (as an adjunct to MAT). Both deliver CBT-based content and contingency management through a smartphone app. Clinical trials found that reSET significantly improved abstinence rates compared to standard outpatient treatment alone.

Somryst (Pear Therapeutics): An FDA-cleared digital therapeutic for chronic insomnia that delivers CBT-I (cognitive behavioral therapy for insomnia) through a smartphone app. Relevant for addiction recovery given the high rates of insomnia in early recovery.

Telehealth for Addiction Treatment

Telehealth has dramatically expanded access to addiction treatment, particularly during and after the COVID-19 pandemic:

Buprenorphine via telehealth: The DEA's COVID-era flexibilities — allowing buprenorphine to be prescribed via telehealth without an in-person evaluation — have been extended, dramatically expanding access to MAT. Research has found that telehealth buprenorphine treatment produces outcomes comparable to in-person treatment.

Telehealth counseling: Video-based individual and group therapy for addiction has been shown to be effective and is preferred by many patients due to its convenience and reduced stigma.

Telehealth limitations: Telehealth is not appropriate for all patients — people with severe addiction requiring medical management, unstable psychiatric conditions, or lack of access to technology may not be appropriate for telehealth-only treatment.

Recovery Support Apps

Numerous smartphone apps provide recovery support, though most have not been rigorously evaluated:

Evidence-based apps:

• A-CHESS (Alcohol Comprehensive Health Enhancement Support System): A smartphone app for alcohol use disorder that provides CBT-based content, GPS-based high-risk location alerts, and peer support. Clinical trials found that A-CHESS significantly reduced risky drinking days.
• CBT4CBT (Computer-Based Training for Cognitive Behavioral Therapy): A web-based CBT program for substance use disorders that has been validated in multiple clinical trials.

Recovery tracking apps: Apps like Sober Grid, I Am Sober, and others provide sobriety tracking, peer support, and recovery resources. While not rigorously evaluated, they are widely used and may support recovery through accountability and community.

Wearable Technology and Addiction

Wearable biosensors are being developed to monitor physiological signals that may indicate stress or craving, enabling just-in-time interventions:

Stress and craving detection: Research has found that physiological signals — including heart rate variability, skin conductance, and accelerometry — can predict stress and craving with reasonable accuracy. Wearable devices that detect these signals could potentially alert the person or their support network when craving is elevated, enabling timely intervention.

Current limitations: Wearable-based craving detection is still in the research phase and is not yet available as a clinical tool. Accuracy, privacy, and implementation challenges remain significant barriers.

Artificial Intelligence in Addiction Treatment

AI is increasingly being applied to addiction treatment:

Personalized treatment matching: AI algorithms are being developed to match patients to the most effective treatments based on their individual characteristics — genetics, brain imaging, clinical features, and treatment history.

Conversational AI: AI-powered chatbots and virtual coaches are being developed to provide 24/7 support, deliver CBT-based content, and monitor for crisis signals. These tools can expand access to support between clinical appointments.

Predictive analytics: AI algorithms can analyze patterns in clinical data to predict relapse risk, enabling proactive intervention.

Frequently Asked Questions

Can apps replace traditional addiction treatment?
No. Digital health tools are adjuncts to, not replacements for, evidence-based addiction treatment. They can expand access, provide between-session support, and deliver evidence-based content, but they cannot replace the therapeutic relationship, medical management, or the comprehensive assessment and treatment planning that professional treatment provides.

Are recovery apps private?
Privacy policies vary significantly among recovery apps. Before using any recovery app, review its privacy policy carefully — particularly regarding data sharing with third parties. Some apps share data with advertisers or other third parties, which may be a concern for people who want to keep their recovery private.

How do I access telehealth addiction treatment?
Many addiction treatment providers now offer telehealth services. SAMHSA's treatment locator can help identify telehealth providers in your area. Telehealth buprenorphine prescribers can be found through the SAMHSA treatment locator and through telehealth platforms specializing in addiction medicine.

Key Takeaways

• Digital health tools — including FDA-cleared digital therapeutics, telehealth, and recovery apps — are expanding access to addiction treatment.
• FDA-cleared digital therapeutics (reSET, reSET-O) have been validated in clinical trials and are effective adjuncts to traditional treatment.
• Telehealth buprenorphine treatment produces outcomes comparable to in-person treatment and dramatically expands access to MAT.
• Digital health tools are adjuncts to, not replacements for, evidence-based addiction treatment.
• Privacy is an important consideration when using recovery apps — review privacy policies carefully.

Additional Resources

Related articles on Sobriety Navigator: Cognitive Behavioral Therapy for Addiction, Medication-Assisted Treatment, Stages of Recovery, Recovery Capital.